
Nxera Pharma To Receive US$4.8 Million In Milestone Payments Following Centessa's Initiation Of Clinical Development Of ...
(MENAFN- GlobeNewsWire - Nasdaq) Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma Co., Ltd. (“Nxera” or“the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuticals pursuant to …